Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jan 15;281 ( Pt 2)(Pt 2):317-23.
doi: 10.1042/bj2810317.

Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment

Affiliations

Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment

D J King et al. Biochem J. .

Abstract

B72.3 is a mouse monoclonal antibody against a tumour-associated antigen, TAG72, which recognizes breast, ovarian and colorectal tumour tissue. A mouse-human chimeric version of B72.3 has been expressed in Chinese-hamster ovary cells. This molecule has the binding specificity of B72.3 and constant regions from human IgG4. The chimeric B72.3 assembles to intact IgG and recognizes TAG72 as well as B72.3 in competitive binding assays. A proportion of the chimeric B72.3 (approx. 10%) does not form inter-heavy-chain disulphide bonds but still assembles into the IgG tetramer. This appears to be a general property of human IgG4 molecules. Co-expression of the chimeric light chain with a chimeric Fd' gene resulted in the expression of functional Fab'. Very little F(ab')2 is produced, although the Fab' can be oxidized to the dimeric F(ab')2 in vitro. The production of Fab' and F(ab')2 by this method is an attractive alternative to proteolytic digestion of IgG. The ability to produce these molecules in large quantities will allow the production and testing of a range of anti-tumour antibody and antibody fragment conjugates.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Res. 1988 Dec 1;48(23):6811-8 - PubMed
    1. Cancer Surv. 1987;6(2):247-67 - PubMed
    1. Cancer Res. 1986 Jun;46(6):3118-24 - PubMed
    1. Protein Eng. 1987 Dec;1(6):499-505 - PubMed
    1. Cancer Res. 1986 Feb;46(2):850-7 - PubMed

MeSH terms

Substances